90 314

Cited 0 times in

Cited 10 times in

Association of serum mineral parameters with mortality in hemodialysis patients: Data from the Korean endstage renal disease registry

DC Field Value Language
dc.contributor.authorKim, Yunmi-
dc.contributor.authorYoo, Kyung Don-
dc.contributor.authorKim, Hyo Jin-
dc.contributor.authorKoh, Junga-
dc.contributor.authorYu, Yeonsil-
dc.contributor.authorKwon, Young Joo-
dc.contributor.authorKim, Gheun-Ho-
dc.contributor.authorYoo, Tae Hyun-
dc.contributor.authorLee, Joongyub-
dc.contributor.authorJin, Dong-Chan-
dc.contributor.authorChoi, Bum Soon-
dc.contributor.authorKim, Yeong Hoon-
dc.contributor.authorOh, Kook-Hwan-
dc.date.accessioned2022-08-16T01:33:17Z-
dc.date.available2022-08-16T01:33:17Z-
dc.date.created2022-06-29-
dc.date.issued2018-09-
dc.identifier.issn2211-9132-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188941-
dc.description.abstractBackground: We investigated the associations between mineral metabolism parameters and mortality to identify optimal targets in Korean hemodialysis patients. Methods: Among hemodialysis patients registered in the end-stage renal disease registry of the Korean Society of Nephrology between March 2012 and June 2017, those with serum calcium, phosphorus, and intact parathyroid hormone (iPTH) measured at enrollment were included. Association of serum levels of calcium, phosphorus, and iPTH with all-cause mortality was analyzed. Results: Among 21,433 enrolled patients, 3,135 (14.6%) died during 24.8 +/- 14.5 months of follow-up. After multivariable adjustment, patients in the first quintile of corrected calcium were associated with lower mortality (hazard ratio [HR], 0.84; 95% confidence interval [95% CI], 0.71-0.99; P = 0.003), while those in the fifth quintile were associated with higher mortality (HR, 1.39; 95% CI, 1.20-1.61; P < 0.001) compared with those in the third quintile. For phosphorus, only the lowest quintile was significantly associated with increased mortality (HR, 1.24; 95% CI, 1.08-1.43; P = 0.003). The lowest (HR, 1.18; 95% CI, 1.02-1.36; P = 0.026) and highest quintiles of iPTH (HR, 1.24; 95% CI, 1.05-1.46; P = 0.013) were associated with increased mortality. For target counts achieved according to the Kidney Disease Outcomes Quality Initiative guideline, patients who did not achieve any mineral parameter targets hadhigher mortality than those who achieved all three targets (HR, 1.37; 95% CI, 1.12-1.67; P = 0.003). Conclusion: In Korean hemodialysis patients, high serum calcium, low phosphorus, and high and low iPTH levels were associated with increased all-cause mortality.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherElsevier Korea-
dc.relation.isPartOfKidney Research and Clinical Practice-
dc.relation.isPartOfKIDNEY RESEARCH AND CLINICAL PRACTICE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleAssociation of serum mineral parameters with mortality in hemodialysis patients: Data from the Korean endstage renal disease registry-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorKim, Yunmi-
dc.contributor.googleauthorYoo, Kyung Don-
dc.contributor.googleauthorKim, Hyo Jin-
dc.contributor.googleauthorKoh, Junga-
dc.contributor.googleauthorYu, Yeonsil-
dc.contributor.googleauthorKwon, Young Joo-
dc.contributor.googleauthorKim, Gheun-Ho-
dc.contributor.googleauthorYoo, Tae Hyun-
dc.contributor.googleauthorLee, Joongyub-
dc.contributor.googleauthorJin, Dong-Chan-
dc.contributor.googleauthorChoi, Bum Soon-
dc.contributor.googleauthorKim, Yeong Hoon-
dc.contributor.googleauthorOh, Kook-Hwan-
dc.identifier.doi10.23876/j.krcp.2018.37.3.266-
dc.relation.journalcodeJ01942-
dc.identifier.eissn2211-9140-
dc.subject.keywordCalcium-
dc.subject.keywordHemodialysis-
dc.subject.keywordMortality-
dc.subject.keywordParathyroid hormone-
dc.subject.keywordPhosphorus-
dc.contributor.alternativeNameYoo, Tae Hyun-
dc.contributor.affiliatedAuthorYoo, Tae Hyun-
dc.identifier.scopusid2-s2.0-85053527043-
dc.identifier.wosid000456124700011-
dc.citation.volume37-
dc.citation.number3-
dc.citation.startPage266-
dc.citation.endPage276-
dc.identifier.bibliographicCitationKidney Research and Clinical Practice, Vol.37(3) : 266-276, 2018-09-
dc.identifier.rimsid74737-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorCalcium-
dc.subject.keywordAuthorHemodialysis-
dc.subject.keywordAuthorMortality-
dc.subject.keywordAuthorParathyroid hormone-
dc.subject.keywordAuthorPhosphorus-
dc.subject.keywordPlusDIALYSIS PATIENTS-
dc.subject.keywordPlusCALCIUM-
dc.subject.keywordPlusPHOSPHORUS-
dc.subject.keywordPlusGUIDELINE-
dc.type.docTypeArticle-
dc.identifier.kciidART002384368-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscopus-
dc.description.journalRegisteredClasskci-
dc.relation.journalWebOfScienceCategoryUrology & Nephrology-
dc.relation.journalResearchAreaUrology & Nephrology-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.